Cargando…
P1539: INFECTION-RELATED MORTALITY CLINICAL-BIOLOGICAL SCORING SYSTEM (IRM-SCORE) AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A VALIDATION STUDY IN GITMO CENTRES
Autores principales: | Clerici, Daniela, Liberatore, Carmine, Rancoita, Paola Maria, Dellacasa, Chiara Maria, Patriarca, Francesca, Corradini, Paolo, Saccardi, Riccardo, Carella, Angelo Michele, Santarone, Stella, Musso, Maurizio, Iori, Anna Paola, Chiusolo, Patrizia, Onida, Francesco, Mordini, Nicola, Gobbi, Marco De, Galieni, Piero, Luppi, Mario, Aglietta, Massimo, Vallisa, Daniele, Storti, Gabriella, Facchini, Luca, Peccatori, Jacopo, Ruggeri, Annalisa, Greco, Raffaella, Corti, Consuelo, Bonifazi, Francesca, Ciceri, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430155/ http://dx.doi.org/10.1097/01.HS9.0000973032.98761.4b |
Ejemplares similares
-
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01
por: Bonifazi, Francesca, et al.
Publicado: (2022) -
Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
por: Patriarca, Francesca, et al.
Publicado: (2020) -
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study
por: Malagola, Michele, et al.
Publicado: (2023) -
P502: PHASE II STUDY ON VENETOCLAX PLUS DECITABINE FOR ELDERLY (≥60 <75YEARS) PATIENTS WITH NEWLY DIAGNOSED HIGH-INTERMEDIATE RISK AML ELEGIBLE FOR ALLO-SCT: MIDTERM UPDATE OF VEN-DEC GITMO STUDY
por: Russo, Domenico, et al.
Publicado: (2023) -
Outcome of Allogeneic Stem Cell Transplantation Following Reduced-Intensity Conditioninig Regimen in Patients With Idiopathic Myelofibrosis: the G.I.T.M.O. Experience
por: Patriarca, Francesca, et al.
Publicado: (2010)